Skip to main content
Log in

Kinetic and dynamic interactions of oral viqualine and ethanol in man

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have studied the interaction of viqualine, a 5-hydroxytryptamine (5-HT) uptake inhibitor, with ethanol in 16 healthy men aged 20 to 34 years. The subjects were randomly assigned to receive ethanol dosed to maintain blood alcohol concentrations of 17–22 mmol · l−1 (n=8) or orange juice (n=8) on each of two test days one week apart and preceded, in random order, by 3 days of viqualine 75 mg bd or placebo.

Ethanol had no effect on steady-state viqualine concentrations or the inhibition of 5-HT uptake.

Viqualine did not affect acetaldehyde concentrations or cause an aversive alcohol-sensitizing reaction.

The deleterious effects of ethanol on word recall, manual tracking, body sway, and self-ratings of intoxication, sedation, and performance were not modified by the presence of viqualine. Within each beverage group performances and self-ratings on viqualine and placebo days were not different. The first dose of viqualine was associated with transient nausea.

Viqualine and ethanol do not interact kinetically or dynamically on the variables examined in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Anthony RM, Sutheimer CA, Sunshine I (1980) Acetaldehyde, methanol, and ethanol analysis by head space gas chromatography. J Anal Toxicol 4: 43–45

    Google Scholar 

  • Eriksson CJP, Yasuhiko M, Tatsushige F (1982) The determination of acetaldehyde in human blood by the perchloric acid precipitation method: The characterization and elimination of artefactual acetaldehyde formation. Anal Biochem 125: 259–263

    Google Scholar 

  • Fourtillan JB, Bouquet S, Girault J, Lefebvre MA, Maulet C, Courtois P (1985) Pharmacokinetics and bioavailability of viqualine a new antidepressant. Eur J Drug Metab Pharmacokinet 10: 3–10

    Google Scholar 

  • Hamilton CA, Sellers EM, Sullivan JT, Kadlec K, Kaplan HL, Naranjo CA (1987) Interactions of fluoxetine (F) and amitriptyline (A) with ethanol. Clin Pharmacol Ther 41: 231

    Google Scholar 

  • Johanson CE, Uhlenhuth EH (1980) Drug preference and mood in humans. Diazepam. Psychopharmacology 71: 269–273

    Google Scholar 

  • Kaplan HL (1987) Incorporating good programs into the larger laboratory context. Behav Res Methods Instr Comput 19: 210–214

    Google Scholar 

  • Kenny M, LeMahan TJ, Lambe R, Brick I, Darragh A, Maulet C (1983) The effect of PK5078, a new serotonin re-uptake inhibitor, on serotonin levels and uptake in human platelets, following administration to healthy volunteers. Eur J Clin Pharmacol 25: 23–28

    Google Scholar 

  • Lader M, Melhuish A, Frcka G, Overo KF, Christensen V (1986) The effect of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 31: 183–190

    Google Scholar 

  • Lemberger L, Rowe H, Bergstrom RF, Farid KZ, Enas GG (1985) Effect of fluoxetine on psychomotor performance, physiologic response and kinetics of ethanol. Clin Pharmacol Ther 37: 658–664

    Google Scholar 

  • Naranjo CA, Sellers EM, Kaplan HL, Hamilton C, Khouw V (1984a) Acute kinetic and dynamic interactions of zimelidine and ethanol. Clin Pharmacol Ther 36: 654–660

    Google Scholar 

  • Naranjo CA, Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K (1984b) Zimelidine-induced variations in ethanol intake by non-depressed heavy drinkers. Clin Pharmacol Ther 35: 374–381

    Google Scholar 

  • Naranjo CA, Sellers EM, Sullivan JT, Kadlec KE, Woodley DV, Kennedy G (1987a) Viqualine-induced attenuation of ethanol intake in early stage problem drinkers. Abstracts Xth Int Congr Pharmacol, Sydney, Australia, P 785

  • Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K (1987b) The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41: 266–274

    Google Scholar 

  • Ross SB, Aperia B, Beck-Friis J, Jansa S, Wetterberg L, Aberg A (1980) Inhibition of 5-hydroxytryptamine uptake in human platelets. Psychopharmacology 67: 1–7

    Google Scholar 

  • Scott DB, Fagan D, Tiplady B (1982) Effects of amitriptyline and zimelidine in combination with ethanol. Psychopharmacology 76: 209–211

    Google Scholar 

  • SPSS Inc (1983) SPSS-X User's Guide. McGraw-Hill, New York

    Google Scholar 

  • Weingartner H, Rudorfer MV, Buchsbaum MS, Linnoila M (1983) Effects of serotonin on memory impairment produced by ethanol. Science 221: 472–474

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The views expressed in this manuscript are those of the authors and do not necessarily reflect those of the Addiction Research Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sullivan, J.T., Naranjo, C.A., Shaw, C.A. et al. Kinetic and dynamic interactions of oral viqualine and ethanol in man. Eur J Clin Pharmacol 36, 93–96 (1989). https://doi.org/10.1007/BF00561033

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561033

Key words

Navigation